Literature DB >> 18722481

The importance of chromogranin A in the development and function of endocrine pancreas.

G M Portela-Gomes1, J R Gayen, L Grimelius, M Stridsberg, S K Mahata.   

Abstract

BACKGROUND: Chromogranin (Cg) A is expressed in neuroendocrine and neuronal tissues. It is involved in the generation of secretory granules and is cleaved to form biologically active peptides. Targeted ablation of the Chga gene resulted in increased plasma catecholamines, high blood pressure, and decreased size and number of adrenal medullary chromaffin granules. The aim of this study was to determine whether Chga null mice display changes in the morphology and function of the endocrine pancreas.
MATERIALS AND METHODS: Sections of pancreata from Chga-/-, Chga+/- and Chga+/+ mice, were immunostained with antibodies against synaptophysin, CgA, CgB, secretogranin II and the four major pancreatic islet hormones. Plasma was analysed for glucose, insulin, glucagon, somatostatin and pancreatic polypeptide (PP).
RESULTS: CgA epitopes were undetectable in the islets of Chga-/- animals. CgB and secretogranin II epitopes were expressed in the islets of all animal groups albeit with decreased expression in Chga-/- islets. The islet number and size were decreased in the Chga-/- animals compared with Chga+/+. The proportion of insulin cells was decreased but somatostatin and PP cells were increased in Chga-/- mice compared to Chga+/+ mice. The nuclear size was decreased in insulin cells and increased in somatostatin cells in Chga-/- mice. Plasma insulin level was markedly decreased in the Chga-/- mice although fasting plasma glucose and glucagon were normal.
CONCLUSION: Ablation of the Chga gene affected the islet volume, the composition, distribution and nuclear size of islet cell types and plasma insulin concentration. Our data indicate decreased insulin cell function and increased glucagon cell function. Our study shows that CgA exerts a significant influence on the endocrine pancreas with importance in maintaining islet volume, cellular composition and function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722481     DOI: 10.1016/j.regpep.2008.07.005

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  7 in total

1.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

2.  Defective secretion of islet hormones in chromogranin-B deficient mice.

Authors:  Stefanie Obermüller; Federico Calegari; Angus King; Anders Lindqvist; Ingmar Lundquist; Albert Salehi; Maura Francolini; Patrizia Rosa; Patrik Rorsman; Wieland B Huttner; Sebastian Barg
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

3.  Targeted multiplex imaging mass spectrometry in transmission geometry for subcellular spatial resolution.

Authors:  Gwendoline Thiery-Lavenant; Andre I Zavalin; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2013-02-09       Impact factor: 3.109

Review 4.  Isolation and Proteomics of the Insulin Secretory Granule.

Authors:  Nicholas Norris; Belinda Yau; Melkam Alamerew Kebede
Journal:  Metabolites       Date:  2021-04-30

5.  Glucose-dependent phosphorylation signaling pathways and crosstalk to mitochondrial respiration in insulin secreting cells.

Authors:  Jaime Santo-Domingo; Antonio Núñez Galindo; Ornella Cominetti; Umberto De Marchi; Pedro Cutillas; Loïc Dayon; Andreas Wiederkehr
Journal:  Cell Commun Signal       Date:  2019-02-20       Impact factor: 5.712

6.  Chromogranin A Deficiency Confers Protection From Autoimmune Diabetes via Multiple Mechanisms.

Authors:  Neetu Srivastava; Hao Hu; Anthony N Vomund; Orion J Peterson; Rocky L Baker; Kathryn Haskins; Luc Teyton; Xiaoxiao Wan; Emil R Unanue
Journal:  Diabetes       Date:  2021-09-08       Impact factor: 9.461

Review 7.  Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges.

Authors:  Isaura Beatriz Borges Silva; Camila Harumi Kimura; Vitor Prado Colantoni; Mari Cleide Sogayar
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.